BrainCells garners $17.7M in round one

San Diego-based BrainCells has raised $17.7 million in its first round of venture capital. Technology Partners and seed investors Oxford Bioscience Partners and Bay City Capital led the round. BrainCells was founded by Fred H. Gage and Harry Hixson in December 2003 to capitalize on Dr. Gage's discoveries that humans generate new nerve cells throughout life and that this endogenous process -- neurogenesis -- can be manipulated using known small molecule therapeutics.

- read this press release for more

PLUS: Cambridge, Massachusetts-based Peptimmune has closed a $20.4 million third round. Release

Suggested Articles

Rachel Humphrey, M.D., who joined CytomX as chief medical officer after heading immuno-oncology at AstraZeneca and Eli Lilly, has made her exit.

Scientists have discovered a scorpion toxin could inspire treatments to block the inflammation that triggers chronic pain.

The phase 2 success keeps Hal Barron’s group on track to file for approval in multiple myeloma by the end of the year.